- SMBC (New York, NY)
- …financial models to: (i) measure and monitor operating and financial performance; ( ii ) adherence to financial covenants; (iii) determine ability to make debt service ... improved financial performance; and (vi) assess repayment ability and enterprise valuations; assign borrower rating, detailed action plans, exposure management… more
- Lumen (New York, NY)
- …shape the future. **The Role** Identifies and develops new Large Enterprise sales opportunities, provides product solutions, ensures customer satisfaction, and ... customers. Responsible for the implementation of strategic and tactical sales account plans. Develops and maintains accurate sales and/or revenue forecasts and… more
- Bristol Myers Squibb (Princeton, NJ)
- …personal lives. Read more: careers.bms.com/working-with-us . **Position Summary** The Director of Early Precision Medicine Regulatory Affairs leads global regulatory ... development, ensuring timely, compliant submissions that support patient stratification in Phase I/ II studies. As a key member of the Translational Medicine CLIA… more
- S&P Global (New York, NY)
- …Level (for internal use):** 12 **About the Role:** **The Team:** S&P Global Enterprise Solutions is seeking to add a high-performing **Sales Associate Director ** ... new business development and pipeline management. + Collaborate closely with account management, product, and cross-functional teams to identify opportunities for… more
- Bristol Myers Squibb (Princeton, NJ)
- …the strategy and integrated development plan for each asset within their portfolio, ( ii ) developing a set of objective criteria against which each asset advancing ... Alignment** + **Inclusively Collaborates Across the BMS Matrix with an Enterprise Mindset:** Effectively collaborates with matrix functions by building trust and… more
- Bristol Myers Squibb (Madison, NJ)
- …efforts + Able to work with other stakeholders to ensure a robust enterprise level strategy for asset(s) and indication(s) including early, late and post-marketing ... development, as well as awareness of the enterprise disease area portfolio + CDL has demonstrated, sustained...assure a seamless transition into late stage development (Phase II -III trials) + Ability to lead and develop a… more
